7.32
-0.18 (-2.4%)
-0.18 (-2.4%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.18 | -2.4% | 7.32 | 08:46:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.31 | 7.32 | 0.01 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 430 | 83,275 | 7,752,560 | 1.08 - 24.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:46:15 | formt | 101 | $ 7.32 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 800.22M | 109.47M | 83.54M | $ 9.86M | $ - | -0.79 | -59.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.40 | 8.45 | 5.68 | 7.17 | 10,063,798 | -0.08 | -1.08% |
| 1 Month | 9.49 | 24.90 | 5.68 | 11.45 | 30,890,918 | -2.17 | -22.87% |
| 3 Months | 7.80 | 24.90 | 5.28 | 10.16 | 15,506,264 | -0.48 | -6.15% |
| 6 Months | 6.93 | 24.90 | 3.50 | 8.14 | 16,667,112 | 0.39 | 5.63% |
| 1 Year | 1.23 | 24.90 | 1.08 | 8.15 | 17,550,436 | 6.09 | 495.12% |
| 3 Years | 5.26 | 24.90 | 0.2543 | 7.43 | 6,723,900 | 2.06 | 39.16% |
| 5 Years | 17.93 | 24.90 | 0.2543 | 7.45 | 4,161,325 | -10.61 | -59.17% |
Vaxart Description
| Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. |
